SAN DIEGO, Nov. 12, 2010 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast its annual briefing for institutional investors and financial analysts at 1 p.m. Pacific Time (PT) / 4 p.m. Eastern Time (ET) on Thursday, December 16, 2010. The event, to be held at Gen-Probe headquarters in San Diego, will feature presentations by senior management on the Company’s current business and future growth strategies. The meeting and webcast are expected to conclude at 4:30 p.m. PT / 7:30 p.m. ET.
The live webcast may be accessed on the investors section of the Company’s web site at www.gen-probe.com. An archived version of the webcast also will be available for at least 30 days.
Institutional investors and financial analysts who wish to attend the meeting in person should RSVP to paula.izidoro@gen-probe.com.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe has approximately 27 years of expertise in nucleic acid testing (NAT), and received the 2004 National Medal of Technology, America’s highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,300 people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our most recent Form 10-K, and all subsequent periodic filings. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
Contact: | |
Paula Izidoro | |
Investor Relations | |
858-410-8904 | |
SOURCE Gen-Probe Incorporated
